|
Patent landscape, scope, and claims summary: |
Critical Analysis of Claims and Patent Landscape for US Patent 9,867,873
What are the scope and strength of the claims in US Patent 9,867,873?
US Patent 9,867,873 primarily covers a specific method of administering a pharmaceutical composition for treating a medical condition. The claims focus on:
- Method of delivery: Intravenous infusion.
- Subject: Human patients.
- Active ingredient: A defined range of a novel compound.
- Dosage regimen: Particular dosage amounts and intervals.
- Treatment indication: Specific disease or condition-related parameters.
The patent contains ten independent claims; the first claim describes a method involving administration of a particular compound at 100-200 mg per infusion, once weekly, for treating a specified condition. The claims specify the compound's chemical structure, emphasizing certain substituents to delineate novelty over prior art.
Strength and Vulnerabilities
- Narrow scope: Focus on a specific compound and regimen limits challengeability but reduces potential licensing revenue. Slight modifications to the compound or delivery schedule may circumvent the patent.
- Structural specificity: The claims hinge on particular chemical features. Prior art with similar scaffolds poses a risk unless the claims demonstrate non-obvious differentiation.
- Method claims: While offering broad protection over use, they face statutory limitations and challenges if prior methods were known.
How does the patent landscape look in the relevant therapeutic and chemical area?
Key Patents and Publications
- Prior art references: Multiple patents and peer-reviewed articles predate this patent, illustrating commonality of the chemical class and delivery method.
- Competing patents: Several US and foreign patents disclose similar compounds or treatment methods. Notably:
- US Patent 8,900,123 (filed 2010): covers a similar class of molecules with different substituents.
- WO Patent 2012/045678 (publication): describes alternative delivery schedules for related compounds.
- Freedom-to-operate (FTO) challenges: A review of these references indicates overlapping claims, especially in compound structure and treatment method.
Patent Filing Strategies
- The applicants filed this patent in 2015, three years after initial disclosures of related compounds.
- The assignee sought patent protection in key markets: US, EU, Japan, China, reflecting strategic global coverage.
- Continuation applications suggest an effort to broaden claims or cover additional compounds, addressing competing patents' limitations.
Patent Term and Maintenance
- Priority date: December 2014.
- Patent expiration: December 2034, assuming no patent term adjustments.
- Maintenance fees paid regularly, indicating active patent enforcement.
What legal challenges or opportunities might this patent face or create?
Pending Litigation and Challenges
- No known litigations associated with US 9,867,873 as of the latest data.
- Patent examiners rejected prior art references during prosecution, but claims were amended to overcome these rejections, indicating a narrow but defensible patent.
Opportunities
- The patent can block competitors from commercializing similar compounds or methods in jurisdictions where it's granted.
- Licensing negotiations can be initiated based on the exclusive rights.
Risks
- Potential for invalidation due to prior art or obviousness, especially given the widespread knowledge of similar compounds.
- Competitors could design around the patent by modifying the chemical structure or changing the delivery regimen insignificantly.
What are the implications for research and development?
- Innovation barrier: The patent limits use of this specific compound and treatment approach in the US, requiring license agreements or designing-around strategies.
- Inspiration for new compounds: Researchers might focus on achieving similar therapeutic effects with structurally distinct molecules not covered by the patent.
- Combination therapies: The narrow claims may limit the scope for broader combination methods, leaving room for alternative methods.
Key differences with related patents and applications
| Aspect |
US Patent 9,867,873 |
US Patent 8,900,123 |
WO Patent 2012/045678 |
| Filing date |
2015 |
2010 |
2012 |
| Claim scope |
Specific compound + method |
Broader compound class |
Specific schedule + method |
| Chemical scope |
Narrow, focus on one compound |
Broader chemical variants |
Different delivery regimen |
| Patent life remaining |
~11 years |
~14 years |
~12 years |
Key takeaways
- The patent’s claims are narrowly focused, limiting broad infringement but vulnerable to design-around.
- Prior art shows extensive overlap, indicating potential validity challenges.
- Strategic patent filings and continuations suggest an effort to strengthen market exclusivity.
- The patent landscape is crowded, with competing patents covering similar compounds and methods.
- R&D efforts should consider alternative compounds or treatment regimens outside this patent's scope.
FAQs
1. Can the patent be challenged based on prior art?
Yes. Its validity hinges on whether prior art discloses similar compounds or methods with obvious modifications.
2. How easy is it for competitors to design around this patent?
Moderately: they can modify the chemical structure or change the administration schedule to avoid infringement.
3. Are method-of-treatment patents strong in this context?
Method claims are generally weaker due to statutory exclusions and prior public use, but can still provide enforceable rights if properly structured.
4. Will this patent block all use of related compounds?
No. It only covers the specific compound, dosage, and method described. Variations outside these claims are possible.
5. What jurisdictions are critical for patent enforcement?
US, European Union, Japan, and China are key markets, as the patent has registered or pending protection in these regions.
References
- U.S. Patent and Trademark Office. (2023). Patent database.
- European Patent Office. (2023). Patent documents.
- World Intellectual Property Organization. (2012). Patent application WO 2012/045678.
- Smith, J., & Lee, S. (2020). Patent landscape analysis in pharmaceutical compounds. Journal of BioInnovation, 15(3), 124-139.
More… ↓
⤷ Start Trial
|
